Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Savara Inc (SVRA)

8.63 -0.32 (-3.58%)

04-25 16:00

Open:

8.95

Pre. Close:

8.95

High:

8.9748

Low:

8.57

Volume:

120,984

Market Cap:

264M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

8.974 - 9.034

9.034 - 9.084

Low:

8.457 - 8.514

8.514 - 8.562

Close:

8.486 - 8.579

8.579 - 8.656

Technical analysis  (as of: 2018-04-25 4:31:19 PM)

Overall:

      

Stoxline posted a SELL today, same as yesterday. This stock seems to continue bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.

Target:

Six months: 11.49     One year: 12.46

Support:

Support1: 8.48    Support2: 7.06

Resistance:

Resistance1: 9.83    Resistance2: 10.67

Pivot:

9.08

Moving Averages:

MA(5): 9.02     MA(20): 9.05

MA(100): 11.89     MA(250): -10000000000.00 -10000000000

MACD:

MACD(12,26): -0.33     Signal(12,26,9): -0.37

%K %D:

%K(14,3): 37.33     %D(3): 50.86

RSI:

RSI(14): 33.36

52-Week:

High: 17.187  Low: 4.6  Change(%): -2.2

Average Vol(K):

3-Month: 14953  10-Days 9727

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
SVRA has closed above bottom band by 5.5%. Bollinger Bands are 57% narrower than normal. The narrow width of the bands suggests low volatility as compared to SVRA's normal range. The bands have been in this narrow range for 8 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

2018-03-16T10:26:29-04:00
Key events next week - healthcare (continued #1)

2018-03-14T21:17:04-04:00
Savara's (SVRA) CEO Robert Neville on Q4 2017 Results - Earnings Call Transcript

2018-03-14T16:07:20-04:00
Savara beats by $0.03

2018-03-13T17:27:17-04:00
Your Daily Pharma Scoop: Portola's New Interim Data, Lantheus Announces Promising Data For LMI 1195, Kura Tumbles On Update

2018-03-13T09:04:15-04:00
Savara launches mid-stage study of lead candidate in lung infection

2018-03-13T07:30:00-04:00
Your Daily Pharma Scoop: Coherus Biosciences Surges, Savara's Aironite Flops, Biogen's SPINRAZA

2018-03-12T10:47:55-04:00
Biotech Forum Daily Digest For March 12th

2018-03-12T09:11:08-04:00
Premarket Losers as of 9:05 am (3/12/2018)

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Therapeutic Drugs

Shares Out. (M)

30.60

Shares Float (M)

22.88

% Held by Insiders

25.30

% Held by Institutions

52.20

Shares Short (K)

558

Shares Short Prior Month (K)

274

Stock Financials

EPS

-3.020

EPS Est. Current Year

-2.350

EPS Est. Next Year

-1.860

EPS Est. Next Quarter

-0.510

Forward EPS

-2.038

Book Value (p.s.)

2.340

PEG Ratio

Profit Margin

Operating Margin

Return on Assets (ttm)

-32.7

Return on Equity (ttm)

-73.8

Qtrly Rev. Growth

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

-0.769

Qtrly Earnings Growth

Operating Cash Flow (M)

-28.23

Levered Free Cash Flow (M)

-15.33

atoplab.com

Valuation

P/E

-2.84

P/E Growth Ratio

-0.04

P/BV

3.66

P/S

P/CF

-9.29

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.